Jun 09, 2022 / 03:00PM GMT
Eun Kyung Yang - Jefferies LLC, Research Division - MD & Senior Equity Research Analyst
Good morning, everyone. This is Eun Yang, a biotech analyst with Jefferies. I'm happy to host a fireside chat with the United Therapeutics. From United Therapeutics is James Edgemond, CFO; and Dewey Steadman, Head of IR.
So before we go into Q&A, Dewey is going to read us a safe harbor statement?
Dewey Steadman - United Therapeutics Corporation - Head of IR
Yes. So today's remarks by James and me will likely contain forward-looking statements, and we caution you to review the risks associated -- risks and uncertainties associated with those statements in our Forms 10-K and 10-Q.
Eun Kyung Yang - Jefferies LLC, Research Division - MD & Senior Equity Research Analyst
Okay. So instead of going -- asking you to an overview of the company, I'm just going to ask questions directly, go into it, given that we have only 25 minutes, okay?
United Therapeutics Corp at Jefferies Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers